Princiotta M F, Schubert U, Chen W, Bennink J R, Myung J, Crews C M, Yewdell J W
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):513-8. doi: 10.1073/pnas.98.2.513. Epub 2001 Jan 9.
The proteasome is the primary protease used by cells for degrading proteins and generating peptide ligands for class I molecules of the major histocompatibility complex. Based on the properties of cells adapted to grow in the presence of the proteasome inhibitor 4-hydroxy-5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone (NLVS), it was proposed that proteasomes can be replaced by alternative proteolytic systems, particularly a large proteolytic complex with a tripeptidyl peptidase II activity. Here we show that NLVS-adapted cells retain sensitivity to a number of highly specific proteasome inhibitors with regard to antigenic peptide generation, accumulation of polyubiquitinated proteins, degradation of p53, and cell viability. In addition, we show that in the same assays (with a single minor exception), NLVS-adapted cells are about as sensitive as nonselected cells to Ala-Ala-Phe-chloromethylketone, a specific inhibitor of tripeptidyl peptidase II activity. Based on these findings, we conclude that proteasomes still have essential proteolytic functions in adapted cells that are not replaced by Ala-Ala-Phe-chloromethylketone-sensitive proteases.
蛋白酶体是细胞用于降解蛋白质并为主要组织相容性复合体I类分子生成肽配体的主要蛋白酶。基于在蛋白酶体抑制剂4-羟基-5-碘-3-硝基苯乙酰基-亮氨酰-亮氨酰-亮氨酰-乙烯砜(NLVS)存在下适应生长的细胞的特性,有人提出蛋白酶体可被替代蛋白水解系统所取代,特别是具有三肽基肽酶II活性的大型蛋白水解复合体。在此我们表明,就抗原肽生成、多聚泛素化蛋白的积累、p53的降解以及细胞活力而言,适应NLVS的细胞对多种高度特异性蛋白酶体抑制剂仍保持敏感性。此外,我们表明在相同的检测中(仅有一个小例外),适应NLVS的细胞对三肽基肽酶II活性的特异性抑制剂丙氨酰-丙氨酰-苯丙氨酸氯甲基酮的敏感性与未选择的细胞大致相同。基于这些发现,我们得出结论,蛋白酶体在适应的细胞中仍具有重要的蛋白水解功能,这些功能不会被对丙氨酰-丙氨酰-苯丙氨酸氯甲基酮敏感的蛋白酶所取代。